Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-001079
Filing Date
2025-01-24
Accepted
2025-01-24 16:16:21
Documents
1
Period of Report
2025-01-22

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 5623
  Complete submission text file 0001062993-25-001079.txt   7254
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2600 KELLY RD WARRINGTON PA 18976
Business Address
Clayton Russell (Reporting) CIK: 0001530072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 25554420